The In Vitro Diagnostics (IVD) Quality Control Market is driven by the increasing prevalence of chronic and infectious diseases, growing adoption of point-of-care testing, and technological ...

Introduction Antimicrobial resistance (AMR) in sexually transmitted infections (STIs) now poses a significant and escalating global threat. Two bacteria&md | Clinical And Molecular Dx ...

DELRAY BEACH, Fla., Sept. 19, 2025 /PRNewswire/ -- The global In Vitro Diagnostics Quality Control Market, valued at US$1.58 billion in 2024, stood at US$1.65 billion in 2025 and is projected to ...

An important scientific study published in The Lancet shows the strong public health impact of deploying molecular diagnostics closer to the people.

The Foundation for Innovative New Diagnostics (FIND), Molbio Diagnostics and the Indian Council of Medical Research (ICMR) announced today that the World Health Organization (WHO) has now endorsed ...

The current pandemic has impacted nearly every aspect of daily life. One strategy to help public health professionals understand and control the spread of SARS-CoV-2 is the widespread testing of ...

Over the past few months, the Molecular Diagnostics market has been prospering well on the back of the COVID-19 havoc, followed by the surge in Monkeypox cases. Apart from these instances, the niche ...

In vitro diagnostics (IVD) is an umbrella term for tests conducted on blood or tissue samples to detect diseases, determine the efficacy of novel or established treatments, and monitor health.